Case Study: Sartorius triples cell line and process development productivity with Genedata Bioprocess

Sartorius Accelerates Cell Line and Process Development by a Factor of 3

Sartorius, a leading global technology provider and CDMO for biopharmaceuticals, faced a critical data and workflow bottleneck as it scaled cell line and upstream process development—relying on Excel and paper for growing volumes of experiments and needing centralized digital workflows, sample tracking, and automation. To solve this challenge, Sartorius chose Genedata and its Genedata Bioprocess enterprise workflow platform to standardize and digitalize their CLD (cell line development) and USP (upstream process) operations.

Genedata deployed the Genedata Bioprocess COTS platform, integrating with Sartorius’ robotics, bioreactors, and analytics to enable fully automated, barcoded end-to-end workflows and real-time data integration. The quick rollout delivered measurable impact: a 3× increase in CLD/USP throughput, more than 30% time savings in documentation, reduced manual errors, faster timelines toward regulatory filings, and support for DNA-to-RCB workflows (≈14 weeks) with scalable production up to 2,000 L.

Sartorius

Hugo de Wit

Head of BA Cell Culture Technologies